Key facts
- This page summarizes Michael Lebowitz's Form 4 filing for XpresSpa Group, Inc. (XWEL).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 31 Jan 2022, 19:10.
Michael Lebowitz - 26 Jan 2022 Form 4 Insider Report for XpresSpa Group, Inc. (XWEL)
- Reporting relationship
- Director
- Issuer ticker
- XWEL
- Reported as of
- 26 Jan 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 31 Jan 2022, 19:10:22 UTC
- Prior SEC filing
- 30 Jul 2021
- Next SEC filing
- 09 Jan 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Cara Soffer, Attorney-in-Fact for Michael Lebowitz
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Michael Lebowitz filed Form 4 for XpresSpa Group, Inc. (XWEL) on 31 Jan 2022.
Change
- Previous filing in this sequence was filed on 30 Jul 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
XWEL
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +31,250
- Change %
- +14%
- Price
- $0.000000
- Shares after
- 259,485
- Date
- 26 Jan 2022
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
XWEL
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +46,875
- Change %
- Price
- $0.000000
- Shares after
- 46,875
- Date
- 26 Jan 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 46,875
- Exercise price
- $1.28
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
These securities were issued as part of the Issuer's equity grant to directors.
Footnote F2
Represents restricted stock units which vest in equal quarterly installments over a one-year period, with one-fourth vesting at the end of each fiscal quarter, such that the options will be fully vested as of December 31, 2022.
Footnote F3
The options vest in equal quarterly installments over a one-year period, with one-fourth vesting at the end of each fiscal quarter, such that the options will be fully vested as of December 31, 2022.